Asset Planning Services (Pennsylvania)’s Acura Pharmaceuticals ACUR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-348
Closed 322
2016
Q4
$0 Hold
348
﹤0.01% 290
2016
Q3
$1K Hold
348
﹤0.01% 269
2016
Q2
$1K Hold
348
﹤0.01% 285
2016
Q1
$1K Hold
348
﹤0.01% 260
2015
Q4
$1K Hold
348
﹤0.01% 232
2015
Q3
$1K Buy
+348
New +$1.18K ﹤0.01% 228

Other funds holding ACUR

Asset Planning Services (Pennsylvania)'s ACUR Position: Q1 2017 in Review

Asset Planning Services (Pennsylvania) sold out of Acura Pharmaceuticals (ACUR) in Q1 2017, closing a stake of 348 shares.

Asset Planning Services (Pennsylvania) first reported a position in ACUR in Q3 2015 and held it in 6 quarters. The position peaked at $1K in Q3 2016. 3 funds tracked by Wall St. Rank hold ACUR as of Q1 2017.

  • Asset Planning Services (Pennsylvania) reported no remaining Acura Pharmaceuticals position as of Q1 2017 after selling out during the quarter.
  • Asset Planning Services (Pennsylvania) sold 348 Acura Pharmaceuticals shares in Q1 2017.
  • Asset Planning Services (Pennsylvania) first reported a position in Acura Pharmaceuticals in Q3 2015 and held it in 6 quarters.
  • Asset Planning Services (Pennsylvania)'s Acura Pharmaceuticals position peaked at $1K in Q3 2016.
  • 3 funds tracked by Wall St. Rank held Acura Pharmaceuticals as of Q1 2017.

Based on Asset Planning Services (Pennsylvania)'s 13F filing for Q1 2017, filed 18 Apr 2017.